tenk.fyi

Insight Molecular Diagnostics Inc.

IMDXNasdaq· In Vitro & In Vivo Diagnostic Substances

Price History

Revenue

$4.1M

115.6% YoY

Net Income

-$50.2M

17.2% YoY

EPS

$-1.65

64.6% YoY

Cash

$11.6M

34.1% YoY

FY 2025 · As of 2025-12-31